Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lynn A. Sleeper, Sc.D.


This page shows the publications co-authored by Lynn Sleeper and Tal Geva.
Connection Strength

  1. Changes in Prognosis of Heterotaxy Syndrome Over Time. Pediatrics. 2020 08; 146(2).
    View in: PubMed
    Score: 0.235
  2. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J. 2006 Sep; 152(3):427-33.
    View in: PubMed
    Score: 0.090
  3. Risk Factors for Left Ventricular Dysfunction Following Surgical Management of Cardiac Fibroma. Circ Cardiovasc Imaging. 2021 Feb; 14(2):e011748.
    View in: PubMed
    Score: 0.061
  4. Relation of Right Ventricular Dilation After Pulmonary Valve Replacement to Outcomes in Patients With Repaired Tetralogy of Fallot. Am J Cardiol. 2020 03 15; 125(6):977-981.
    View in: PubMed
    Score: 0.057
  5. Maldistribution of pulmonary blood flow in patients after the Fontan operation is associated with worse exercise capacity. J Cardiovasc Magn Reson. 2018 12 17; 20(1):85.
    View in: PubMed
    Score: 0.053
  6. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018 05; 104(9):738-744.
    View in: PubMed
    Score: 0.049
  7. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation. 2010 Jan 05; 121(1):34-42.
    View in: PubMed
    Score: 0.028
  8. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008 Jul 08; 52(2):85-98.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.